News & Insights

GLP-1 injectable syringe.
Evaluating the Mental Health Effects of GLP-1 Drugs in Individuals with Obesity
How does GLP-1 use impact psychological wellbeing in adults with diabetes and obesity? A recent study published in JAMA Psychiatry sought to
News & Insights
FDA Grants Accelerated Review to Three Psychedelic Drugs
The FDA announced on Friday, April 24th that three psychedelic drugs have been granted expedited review vouchers, the first
988 Mental Health Crisis Hotline Linked to Decline in Youth Suicides
A recent study published in JAMA shows a promising sign of improvement in the youth mental health crisis – the 988 national
New Executive Order Eases Restrictions on Psychedelics
On April 18th, 2026, President Trump signed an executive order easing federal restrictions on psychedelic substances with
Florida Sues OpenAI Over ChatGPT Safety, Citing Youth Self-Harm Risk and Consumer Protection Violations
Florida has filed a state lawsuit against OpenAI and CEO Sam Altman, alleging the company aggressively marketed ChatGPT to

All Content

Childhood neglect
Childhood Emotional Neglect in Adult Relationships: Signs, Causes, and Therapy Strategies
Childhood emotional neglect (CEN) rarely looks dramatic. Instead of overt abuse, it’s the everyday absence of attunement—caregivers who miss
News & Insights
Neuroplastic
How Integrated Neuroplastic Therapy Is Redefining Mental Health Care in 2026
NRx Pharmaceuticals (NASDAQ: NRXP) and neurocare Group AG announced a nationwide partnership to offer integrated neuroplastic therapy for
News & Insights
Healing Hands
Healing Requires More than a Prescription
Medscape’s commentary, “No Pill for the Human Condition,” makes a timely, clear point: drugs can lower symptom burden, but they cannot
News & Insights
Brain
Illinois’ WOPR Act: A New Standard for Ethical AI in Mental-Health Care
On August 8, 2025, Illinois became the first U.S. state to formally restrict AI from delivering therapeutic or diagnostic services under the
News & Insights
Back to top